wersja polska printable version
	kwartalnik ISSN 0500-7208 Czasopismo punktowane przez KBN, Index Copernicus oraz w bazie GBL

1. 1. Johnson B, Christensen C, DiRusso S et al: A need for reevaluation of sports participation recommendations for children with solitary kidney. J Urol 2005, 174, 686-689.
2. 2. Paparel Ph, N'Diaye A, Chiron M et al: Nature et mecanismes de 54 traumatismes du rein chez des automobilists victims d' accidents de la circulation. Prog Urol 2005, 15, 416-419.
3. 3. Sheir KZ, El-Azab M, Mosbach A et al: Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol 2005, 174, 451-455.
4. 4. Katz AE, Mallick P, Agus DB: A perspective on protein profiling of blood. BJU International 2005, 96, 477-482.
5. 5. Smith SC, Oxford G, Theodorescu G: The promise of gene-expression analysis in bladder cancer, a clinician's guide. BJU International 2005, 95, 874-880.
6. 6. Bollmann M, Heller H, Bankfalvi A et al: Quantitative molecular urinary cytology by fluorescence in situ hybridization, a tool for tailoring surveillance of patients with superficial bladder cancer. BJU International 2005, 95, 1219-1225.
7. 7. Mariappan P, Smith G: A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and save discharge at 5 years based on a 25-year prospective database. J Urol 2005, 173, 1108-1111.
8. 8. Shariat FS, Zippe C, Ludecke G et al: Nomograms including nuclear matrix protein 22 for prediction of disease reccurence and progression with Ta, T1 or CIS transitional cell carcinoma of the bladder. J Urol 2005, 173, 1518-1525.
9. 9. Skolarikos A, Chrisofos M, Ferakis N et al: Does management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor reccurence? J Urol 2005, 173, 1908-1911.
10. 10. Moskovitz B, Meyer G, Kravtzov A et al: Thermo-chemotherapy for intermediate or high-risk superficial bladder cancer patients. Annals of Oncology 2005, 16, 585-589.
11. 11. Wiesner Ch, Pfitzenmaier J, Faldum A et al: Lymph node metastases In non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy. BJU International 2005, 95, 301-305.
12. 12. Cheng L, Pan Ch-X, Yang XJ et al: Small cell carcinoma of the urinary bladder. Cancer 2004, 101, 957-962.
13. 13. El-Tabey, Osman Y, Mosbah A et al: Bladder cancer with obstructive uremia, oncologic outcome after definitive surgical management. Urology 2005, 66, 531-35.
14. 14 Herr HW, Faulkner JR, Grossman HB et al: Surgical factors influence blader cancer outcomes, a cooperative group report. J Clin Oncol 2004, 22, 2781-2789.
15. 15. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer, update of a systematic review and meta-analysis of individual patient data. Eur Urol 2005, 48, 202-206.
16. 16. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer, a systematic review and meta-analysis of individual patient data. Eur Urol 2005, 48, 189-201.
17. 17. Israel GM, Bosniak MA: An update of the Bosniak renal cyst classification system. Urology 2005, 66, 484-488.
18. 18. Levi F, Lucchini F, Negri E et al: Declining mortality from kidney cancer in Europe. Annals of Oncology 2004, 15, 1130-1135.
19. 19. Langner C, Ratschek M, Rehak P et al: The pT1a and pT1b category subdivision in renal cell carcinoma, is it reflected by differences in tumor biology. BJU International 2004, 95, 310-314.
20. 20. Murphy AM, Gilbert SM, Katz AE et al: Re-evaluation of the Tumor-Node-Metastasis staging of locally advanced renal cortical tumours, absolute size (T2) is more significant than renal capsular invasion (T3a). BJU International 2004, 95, 27-30.
21. 21. Thompson RH, Leibovich BC, Cheville JC et al: Is renal sinus fat invasion the same as perinehric fat invasion for pT3a renal cell carcinoma. J Urol 2005, 174, 1218-1221.
22. 22. Holmang S, Johansson SL: Synchronous bilateral ureteral and renal pelvic carcinomas. Cancer 2004, 101, 741-747.
23. 23. Mullerad M, Russo P, Golijanin D et al: Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol 2004, 172, 2177-2181.
24. 24. Lapini A, Serni S, Minervini A et al: Progression and long-term survival after simple enucleation for the elective treatment of renal cell carcinoma, experience in 107 patients. JUrol 2005, 174, 57-60.
25. 25. Patard J-J, Kim HL, Lam JS et al: Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma, an international multicenter study. J Clin Oncol 2004, 22, 3316-3322.
26. 26. Sorbellini M, Kattan MW, Snyder ME et al: A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005, 173, 48-51.
27. 27. Kim HL, Seligson D, Liu X et al: Using tumors markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol 2005, 173, 1496-1501.
28. 28. Artz AS, Van Besien K, Zimmerman T et al: Long term follow-up of nonmyeloablative allogenic stem cell transplantation for renal cell carcinoma, The University of Chicago experience. Bone Marrow Transplantation 2005, 35, 253-260
29. 29. Kroon BK, Horenblas S, Meinhardt W et al: Dynamic sentinel node biopsy in penile carcinoma, evaluation of 10 yars experience. Eur Urol 2005, 47, 601-606.
30. 30. Kommu S, Hadway P, Watkin N: Squamous cell carcinoma antigen as a biomarker for penile cancer. BJU International 2005, 95, 478-479.

prof. dr hab. Andrzej Borkowski
Klinika Urologii AM
ul. Lindleya 4
02-500 Warszawa
tel. (022) 502 17 23
urolwa@warman.com.pl